Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.

Wentzensen N, Walker J, Smith K, Gold MA, Zuna R, Massad LS, Liu A, Silver MI, Dunn ST, Schiffman M.

Am J Obstet Gynecol. 2018 Feb 17. pii: S0002-9378(18)30153-4. doi: 10.1016/j.ajog.2018.02.009. [Epub ahead of print]

PMID:
29462629
2.

Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years.

Silver MI, Gage JC, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Katki HA, Locke A, Kinney WK, Castle PE.

Cancer Prev Res (Phila). 2018 Feb 5. pii: canprevres.0293.2017. doi: 10.1158/1940-6207.CAPR-17-0293. [Epub ahead of print]

PMID:
29437696
3.

Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.

Silver MI, Rositch AF, Phelan-Emrick DF, Gravitt PE.

Cancer Causes Control. 2018 Jan;29(1):43-50. doi: 10.1007/s10552-017-0976-x. Epub 2017 Nov 9.

PMID:
29124542
4.

ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards.

Waxman AG, Conageski C, Silver MI, Tedeschi C, Stier EA, Apgar B, Huh WK, Wentzensen N, Massad LS, Khan MJ, Mayeaux EJ Jr, Einstein MH, Schiffman MH, Guido RS.

J Low Genit Tract Dis. 2017 Oct;21(4):235-241. doi: 10.1097/LGT.0000000000000336.

PMID:
28953112
5.

ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice.

Wentzensen N, Schiffman M, Silver MI, Khan MJ, Perkins RB, Smith KM, Gage JC, Gold MA, Conageski C, Einstein MH, Mayeaux EJ Jr, Waxman AG, Huh WK, Massad LS.

J Low Genit Tract Dis. 2017 Oct;21(4):230-234. doi: 10.1097/LGT.0000000000000334.

PMID:
28953111
6.

Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.

Wentzensen N, Massad LS, Mayeaux EJ Jr, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, Chelmow D, Choma KK, Darragh TM, Gage JC, Garcia FAR, Guido RS, Jeronimo JA, Liu A, Mathews CA, Mitchell MM, Moscicki AB, Novetsky AP, Papasozomenos T, Perkins RB, Silver MI, Smith KM, Stier EA, Tedeschi CA, Werner CL, Huh WK.

J Low Genit Tract Dis. 2017 Oct;21(4):216-222. doi: 10.1097/LGT.0000000000000322.

PMID:
28953109
7.

Engineering the production of conjugated fatty acids in Arabidopsis thaliana leaves.

Yurchenko O, Shockey JM, Gidda SK, Silver MI, Chapman KD, Mullen RT, Dyer JM.

Plant Biotechnol J. 2017 Aug;15(8):1010-1023. doi: 10.1111/pbi.12695. Epub 2017 Mar 15.

8.

Trends in cervical cancer incidence in younger US women from 2000 to 2013.

Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS.

Gynecol Oncol. 2017 Feb;144(2):391-395. doi: 10.1016/j.ygyno.2016.11.031. Epub 2016 Nov 26.

9.

The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.

Silver MI, Schiffman M, Fetterman B, Poitras NE, Gage JC, Wentzensen N, Lorey T, Kinney WK, Castle PE.

Cancer. 2016 Dec 1;122(23):3682-3686. doi: 10.1002/cncr.30277. Epub 2016 Sep 22.

10.

Biomarkers for Cervical Cancer Prevention Programs: The Long and Winding Road From Discovery to Clinical Use.

Wentzensen N, Silver MI.

J Low Genit Tract Dis. 2016 Jul;20(3):191-4. doi: 10.1097/LGT.0000000000000231. No abstract available.

PMID:
27243141
11.

Race is Associated With Sexual Behaviors and Modifies the Effect of Age on Human Papillomavirus Serostatus Among Perimenopausal Women.

Rettig EM, Fakhry C, Rositch AF, Burke AE, Chang K, Silver MI, Viscidi R, Gravitt P.

Sex Transm Dis. 2016 Apr;43(4):231-7. doi: 10.1097/OLQ.0000000000000426.

PMID:
26967299
12.

Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.

Silver MI, Rositch AF, Burke AE, Chang K, Viscidi R, Gravitt PE.

Obstet Gynecol. 2015 Feb;125(2):317-29. doi: 10.1097/AOG.0000000000000638.

13.

Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples.

Low HC, Silver MI, Brown BJ, Leng CY, Blas MM, Gravitt PE, Woo YL.

J Clin Microbiol. 2015 Feb;53(2):550-6. doi: 10.1128/JCM.02274-14. Epub 2014 Dec 10.

14.

Cervical cancer screening in older women: new evidence and knowledge gaps.

Rositch AF, Silver MI, Gravitt PE.

PLoS Med. 2014 Jan;11(1):e1001586. doi: 10.1371/journal.pmed.1001586. Epub 2014 Jan 14. No abstract available.

15.

Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.

Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE.

Menopause. 2014 May;21(5):450-8. doi: 10.1097/GME.0b013e3182a4690b.

16.

Obesity and human papillomavirus infection in perimenopausal women.

Liu SH, Rositch AF, Viscidi RP, Silver MI, Burke AE, Gravitt PE.

J Infect Dis. 2013 Oct 1;208(7):1071-80. doi: 10.1093/infdis/jit297. Epub 2013 Jul 9.

17.

A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.

Gravitt PE, Rositch AF, Silver MI, Marks MA, Chang K, Burke AE, Viscidi RP.

J Infect Dis. 2013 Jan 15;207(2):272-80. doi: 10.1093/infdis/jis660. Epub 2012 Dec 12.

18.

Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women.

Rositch AF, Burke AE, Viscidi RP, Silver MI, Chang K, Gravitt PE.

Cancer Res. 2012 Dec 1;72(23):6183-90. doi: 10.1158/0008-5472.CAN-12-2635. Epub 2012 Sep 27.

19.

The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women.

Rositch AF, Silver MI, Burke A, Viscidi R, Chang K, Duke CM, Shen W, Gravitt PE.

J Low Genit Tract Dis. 2013 Jan;17(1):38-47. doi: 10.1097/LGT.0b013e3182503402.

20.

Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India.

Silver MI, Paul P, Sowjanya P, Ramakrishna G, Vedantham H, Kalpana B, Shah KV, Gravitt PE.

J Clin Microbiol. 2011 Jul;49(7):2435-9. doi: 10.1128/JCM.02206-10. Epub 2011 Apr 27.

21.

Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India.

Vedantham H, Silver MI, Kalpana B, Rekha C, Karuna BP, Vidyadhari K, Mrudula S, Ronnett BM, Vijayaraghavan K, Ramakrishna G, Sowjanya P, Laxmi S, Shah KV, Gravitt PE; CATCH Study Team.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1373-80. doi: 10.1158/1055-9965.EPI-09-1282.

22.

Providing dialysis services for patients in a skilled nursing facility.

Silver MI.

Nephrol News Issues. 1999 Oct;13(10):14-9. No abstract available.

PMID:
10827671
23.

Standardization of services needed to define role.

Silver MI.

Provider. 1990 Jul;16(7):20. No abstract available.

PMID:
10105229

Supplemental Content

Loading ...
Support Center